Growth Metrics

Ligand Pharmaceuticals (LGND) EPS (Weighted Average and Diluted) (QoQ) (2010 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn -
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn
7 Evaxion A 64.16 Bn 64.14 Bn -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn
10 Ligand Pharmaceuticals 4.61 Bn 3.83 Bn 48.45 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -130.73%
Dec 31, 2025 -61.62%
Sep 30, 2025 2,266.67%
Jun 30, 2025 110.86%
Mar 31, 2025 -31.55%
Dec 31, 2024 -330.77%
Sep 30, 2024 86.46%
Jun 30, 2024 -160.63%
Mar 31, 2024 361.17%
Dec 31, 2023 274.58%
Sep 30, 2023 -553.85%
Jun 30, 2023 -94.65%
Mar 31, 2023 382.56%
Dec 31, 2022 -253.57%
Sep 30, 2022 -24.32%
Jun 30, 2022 196.10%
Mar 31, 2022 -305.26%
Dec 31, 2021 -115.97%
Sep 30, 2021 -43.87%
Jun 30, 2021 60.61%
Mar 31, 2021 277.14%
Dec 31, 2020 183.33%
Sep 30, 2020 -131.82%
Jun 30, 2020 190.41%
Mar 31, 2020 -239.53%
Dec 31, 2019 46.91%
Sep 30, 2019 -9.46%
Jun 30, 2019 -102.36%
Mar 31, 2019 1,650.50%
Dec 31, 2018 -172.14%
Sep 30, 2018 -6.35%
Jun 30, 2018 63.39%
Mar 31, 2018 190.59%
Dec 31, 2017 -172.14%
Sep 30, 2017 -6.35%
Jun 30, 2017 63.39%
Mar 31, 2017 1,120.00%
Dec 31, 2016 200.00%
Sep 30, 2016 116.67%
Jun 30, 2016 -200.00%
Mar 31, 2016 3.45%
Dec 31, 2015 -96.88%
Sep 30, 2015 736.04%
Jun 30, 2015 2,675.00%
Mar 31, 2015 -88.24%
Dec 31, 2014 466.67%
Sep 30, 2014 -14.29%
Jun 30, 2014 -30.00%
Mar 31, 2014 11.11%
Dec 31, 2013 0.00%
Sep 30, 2013 -70.00%
Jun 30, 2013 328.57%
Mar 31, 2013 216.67%
Dec 31, 2012 -500.00%
Sep 30, 2012 95.45%
Jun 30, 2012 -232,197.07%
Mar 31, 2011 -99.81%
Dec 31, 2010 17,873.43%
Sep 30, 2010 71.13%